stella
beta
Recruiting
Back to Advanced Clear Cell Renal Cell Carcinoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(2 sites)
United States
City of Hope Medical Center, Duarte, California
City of Hope Medical Center, Irvine, California
View full record on ClinicalTrials.gov
Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer — Stella